Myeloid cell transmigration across the CNS vasculature triggers IL-1ß-driven neuroinflammation during autoimmune encephalomyelitis in mice

Journal of Experimental Medicine

Volumn 213, Issue 6, 2016, Pages 929-949

  Lévesque, Sébastien A ^a   Paré, Alexandre ^a   Mailhot, Benoit ^a   Bellver Landete, Victor ^a   Kébir, Hania ^b   Lécuyer, Marc André ^b   Alvarez, Jorge Ivan ^b,c   Prat, Alexandre ^b   de Rivero Vaccari, Juan Pablo ^d   Keane, Robert W ^e   Lacroix, Steve ^a  

^a LAVAL UNIVERSITY   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF MIAMI   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; IL1B PROTEIN, MOUSE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL ISOLATION; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; LEUKOCYTE; MALE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIMARY CULTURE; PRIORITY JOURNAL; SPINAL CORD; VASCULARIZATION; ANIMAL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE; MULTIPLE SCLEROSIS; NEUTROPHIL; PARACRINE SIGNALING; PATHOLOGY; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERLEUKIN-1BETA; MACROPHAGES; MICE; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; NEUTROPHILS; PARACRINE COMMUNICATION; SPINAL CORD; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 84971554433     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20151437     Document Type: Article

References (71)

1. Aubé, B., S.A. Lévesque, A. Paré, É. Chamma, H. Kébir, R. Gorina, M.A. Lécuyer, J.I. Alvarez, Y. De Koninck, B. Engelhardt, et al. 2014. Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases. J. Immunol. 193:2438-2454 (PubMed). http://dx.doi.org/10.4049/jimmunol.1400401
2. Badovinac, V., M. Mostarica-Stojkovic, C.A. Dinarello, and S. Stosic-Grujicic. 1998. Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells. J. Neuroimmunol. 85:87-95. http://dx.doi.org/10.1016/S0165-5728(98)00020-4
3. Barrette, B., M.A. Hébert, M. Filali, K. Lafortune, N. Vallières, G. Gowing, J.P. Julien, and S. Lacroix. 2008. Requirement of myeloid cells for axon regeneration. J. Neurosci. 28:9363-9376. http://dx.doi.org/10.1523/JNEUROSCI.1447-08.2008
4. Bastien, D., V. Bellver Landete, M. Lessard, N. Vallières, M. Champagne, A. Takashima, M.E. Tremblay, Y. Doyon, and S. Lacroix. 2015. IL-1α gene deletion protects oligodendrocytes after spinal cord injury through upregulation of the survival factor Tox3. J. Neurosci. 35:10715-10730. http://dx.doi.org/10.1523/JNEUROSCI.0498-15.2015
5. Campbell, S.J., U. Meier, S. Mardiguian, Y. Jiang, E.T. Littleton, A. Bristow, J. Relton, T.J. Connor, and D.C. Anthony. 2010. Sickness behaviour is induced by a peripheral CXC-chemokine also expressed in multiple sclerosis and EAE. Brain Behav. Immun. 24:738-746. http://dx.doi.org/10.1016/j.bbi.2010.01.011
6. Cannella, B., and C.S. Raine. 1995. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37:424-435. http://dx.doi.org/10.1002/ana.410370404
7. Carare, R.O., M. Bernardes-Silva, T.A. Newman, A.M. Page, J.A. Nicoll, V.H. Perry, and R.O. Weller. 2008. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol. Appl. Neurobiol. 34:131-144. http://dx.doi.org/10.1111/j.1365-2990.2007.00926.x
8. + CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J. Exp. Med. 205:811-823. http://dx.doi.org/10.1084/jem.20072404
9. Carpintero, R., and D. Burger. 2011. IFNß and glatiramer acetate trigger different signaling pathways to regulate the IL-1 system in multiple sclerosis. Commun. Integr. Biol. 4:112-114. http://dx.doi.org/10.4161/cib.14205
10. Carrieri, P.B., V. Provitera, T. De Rosa, G. Tartaglia, F. Gorga, and O. Perrella. 1998. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity. Immunopharmacol. Immunotoxicol. 20:373-382. http://dx.doi.org/10.3109/08923979809034820
11. Codarri, L., G. Gyülvészi, V. Tosevski, L. Hesske, A. Fontana, L. Magnenat, T. Suter, and B. Becher. 2011. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12:560-567. http://dx.doi.org/10.1038/ni.2027
12. Compston, A. 2004. The pathogenesis and basis for treatment in multiple sclerosis. Clin. Neurol. Neurosurg. 106:246-248. http://dx.doi.org/10.1016/j.clineuro.2004.02.007
13. Dalkara, T., Y. Gursoy-Ozdemir, and M. Yemisci. 2011. Brain microvascular pericytes in health and disease. Acta Neuropathol. 122:1-9. http://dx.doi.org/10.1007/s00401-011-0847-6
14. de Jong, B.A., T.W. Huizinga, E.L. Bollen, B.M. Uitdehaag, G.P. Bosma, M.A. van Buchem, E.J. Remarque, A.C. Burgmans, N.F. Kalkers, C.H. Polman, and R.G. Westendorp. 2002. Production of IL-1ß and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis. J. Neuroimmunol. 126:172-179. http://dx.doi.org/10.1016/S0165-5728(02)00056-5
15. de Rivero Vaccari, J.P., D. Bastien, G. Yurcisin, I. Pineau, W.D. Dietrich, Y. De Koninck, R.W. Keane, and S. Lacroix. 2012. P2X4 receptors influence inflammasome activation after spinal cord injury. J. Neurosci. 32:3058-3066. http://dx.doi.org/10.1523/JNEUROSCI.4930-11.2012
16. Dinarello, C.A. 2009. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27:519-550. http://dx.doi.org/10.1146/annurev.immunol.021908.132612
17. Dinarello, C.A. 2011. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 117:3720-3732. http://dx.doi.org/10.1182/blood-2010-07-273417
18. H17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12:568-575. http://dx.doi.org/10.1038/ni.2031
19. Eugster, H.P., K. Frei, M. Kopf, H. Lassmann, and A. Fontana. 1998. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28:2178-2187. http://dx.doi.org/10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D
20. 35-55-induced experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther. 14:93-98. http://dx.doi.org/10.1038/sj.gt.3302805
21. Geng, S., H. Matsushima, T. Okamoto, Y. Yao, R. Lu, K. Page, R.M. Blumenthal, N.L. Ward, T. Miyazaki, and A. Takashima. 2013. Emergence, origin, and function of neutrophil-dendritic cell hybrids in experimentally induced inflammatory lesions in mice. Blood. 121:1690-1700. http://dx.doi.org/10.1182/blood-2012-07-445197
22. Holman, D.W., R.S. Klein, and R.M. Ransohoff. 2011. The blood-brain barrier, chemokines and multiple sclerosis. Biochim. Biophys. Acta. 1812:220-230. http://dx.doi.org/10.1016/j.bbadis.2010.07.019
23. Horai, R., M. Asano, K. Sudo, H. Kanuka, M. Suzuki, M. Nishihara, M. Takahashi, and Y. Iwakura. 1998. Production of mice deficient in genes for interleukin (IL)-1α, IL-1ß, IL-1α/ß, and IL-1 receptor antagonist shows that IL-1ß is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 187:1463-1475. http://dx.doi.org/10.1084/jem.187.9.1463
24. Huang, D.R., J. Wang, P. Kivisakk, B.J. Rollins, and R.M. Ransohoff. 2001. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J. Exp. Med. 193:713-726. http://dx.doi.org/10.1084/jem.193.6.713
25. Ifergan, I., H. Kébir, M. Bernard, K. Wosik, A. Dodelet-Devillers, R. Cayrol, N. Arbour, and A. Prat. 2008. The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain. 131:785-799. http://dx.doi.org/10.1093/brain/awm295
26. Ishizu, T., M. Osoegawa, F.J. Mei, H. Kikuchi, M. Tanaka, Y. Takakura, M. Minohara, H. Murai, F. Mihara, T. Taniwaki, and J. Kira. 2005. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain. 128:988-1002. http://dx.doi.org/10.1093/brain/awh453
27. Jacobs, C.A., P.E. Baker, E.R. Roux, K.S. Picha, B. Toivola, S. Waugh, and M.K. Kennedy. 1991. Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor. J. Immunol. 146:2983-2989.
28. Kroenke, M.A., T.J. Carlson, A.V. Andjelkovic, and B.M. Segal. 2008. IL-12-and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 205:1535-1541. http://dx.doi.org/10.1084/jem.20080159
29. Kroenke, M.A., S.W. Chensue, and B.M. Segal. 2010. EAE mediated by a non-IFN-γ/non-IL-17 pathway. Eur. J. Immunol. 40:2340-2348. http://dx.doi.org/10.1002/eji.201040489
30. Krueger, M., and I. Bechmann. 2010. CNS pericytes: concepts, misconceptions, and a way out. Glia. 58:1-10. http://dx.doi.org/10.1002/glia.20898
31. Lee, Y., A. Awasthi, N. Yosef, F.J. Quintana, S. Xiao, A. Peters, C. Wu, M. Kleinewietfeld, S. Kunder, D.A. Hafler, et al. 2012. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13:991-999. http://dx.doi.org/10.1038/ni.2416
32. Lewis, N.D., J.D. Hill, K.W. Juchem, D.E. Stefanopoulos, and L.K. Modis. 2014. RNA sequencing of microglia and monocyte-derived macrophages from mice with experimental autoimmune encephalomyelitis illustrates a changing phenotype with disease course. J. Neuroimmunol. 277:26-38. http://dx.doi.org/10.1016/j.jneuroim.2014.09.014
33. Li, Q., N. Powell, H. Zhang, N. Belevych, S. Ching, Q. Chen, J. Sheridan, C. Whitacre, and N. Quan. 2011. Endothelial IL-1R1 is a critical mediator of EAE pathogenesis. Brain Behav. Immun. 25:160-167. http://dx.doi.org/10.1016/j.bbi.2010.09.009
34. Liu, X., T. Yamashita, Q. Chen, N. Belevych, D.B. Mckim, A.J. Tarr, V. Coppola, N. Nath, D.P. Nemeth, Z.W. Syed, et al. 2015. Interleukin 1 type 1 receptor restore: a genetic mouse model for studying interleukin 1 receptor-mediated effects in specific cell types. J. Neurosci. 35:2860-2870. http://dx.doi.org/10.1523/JNEUROSCI.3199-14.2015
35. + T cells and γδ T cells. J. Immunol. 188:3107-3115. http://dx.doi.org/10.4049/jimmunol.1103308
36. Mason, J.L., K. Suzuki, D.D. Chaplin, and G.K. Matsushima. 2001. Interleukin-1beta promotes repair of the CNS. J. Neurosci. 21:7046-7052.
37. Matsuki, T., S. Nakae, K. Sudo, R. Horai, and Y. Iwakura. 2006. Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis. Int. Immunol. 18:399-407. http://dx.doi.org/10.1093/intimm/dxh379
38. Matsushima, H., Y. Ogawa, T. Miyazaki, H. Tanaka, A. Nishibu, and A. Takashima. 2010. Intravital imaging of IL-1ß production in skin. J. Invest. Dermatol. 130:1571-1580. http://dx.doi.org/10.1038/jid.2010.11
39. Matsushima, H., S. Geng, R. Lu, T. Okamoto, Y. Yao, N. Mayuzumi, P.F. Kotol, B.J. Chojnacki, T. Miyazaki, R.L. Gallo, and A. Takashima. 2013. Neutrophil differentiation into a unique hybrid population exhibiting dual phenotype and functionality of neutrophils and dendritic cells. Blood. 121:1677-1689. http://dx.doi.org/10.1182/blood-2012-07-445189
40. Matsushita, T., T. Tateishi, N. Isobe, T. Yonekawa, R. Yamasaki, D. Matsuse, H. Murai, and J. Kira. 2013. Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis. PLoS One. 8:e61835. http://dx.doi.org/10.1371/journal.pone.0061835
41. McCandless, E.E., L. Piccio, B.M. Woerner, R.E. Schmidt, J.B. Rubin, A.H. Cross, and R.S. Klein. 2008. Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. Am. J. Pathol. 172:799-808. http://dx.doi.org/10.2353/ajpath.2008.070918
42. McCandless, E.E., M. Budde, J.R. Lees, D. Dorsey, E. Lyng, and R.S. Klein. 2009. IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis. J. Immunol. 183:613-620. http://dx.doi.org/10.4049/jimmunol.0802258
43. McGuinness, M.C., J.M. Powers, W.B. Bias, B.J. Schmeckpeper, A.H. Segal, V.C. Gowda, S.L. Wesselingh, J. Berger, D.E. Griffin, and K.D. Smith. 1997. Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis. J. Neuroimmunol. 75:174-182. http://dx.doi.org/10.1016/S0165-5728(97)00020-9
44. McQualter, J.L., R. Darwiche, C. Ewing, M. Onuki, T.W. Kay, J.A. Hamilton, H.H. Reid, and C.C. Bernard. 2001. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194:873-882. http://dx.doi.org/10.1084/jem.194.7.873
45. Mellergård, J., M. Edström, M. Vrethem, J. Ernerudh, and C. Dahle. 2010. Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid. Mult. Scler. 16:208-217. http://dx.doi.org/10.1177/1352458509355068
46. Miranda-Hernandez, S., N. Gerlach, J.M. Fletcher, E. Biros, M. Mack, H. Körner, and A.G. Baxter. 2011. Role for MyD88, TLR2 and TLR9 but not TLR1, TLR4 or TLR6 in experimental autoimmune encephalomyelitis. J. Immunol. 187:791-804. http://dx.doi.org/10.4049/jimmunol.1001992
47. Nourshargh, S., P.L. Hordijk, and M. Sixt. 2010. Breaching multiple barriers: leukocyte motility through venular walls and the interstitium. Nat. Rev. Mol. Cell Biol. 11:366-378. http://dx.doi.org/10.1038/nrm2889
48. Okuda, Y., S. Sakoda, C.C. Bernard, H. Fujimura, Y. Saeki, T. Kishimoto, and T. Yanagihara. 1998. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int. Immunol. 10:703-708. http://dx.doi.org/10.1093/intimm/10.5.703
49. Parkhurst, C.N., G. Yang, I. Ninan, J.N. Savas, J.R. Yates III, J.J. Lafaille, B.L. Hempstead, D.R. Littman, and W.B. Gan. 2013. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 155:1596-1609. http://dx.doi.org/10.1016/j.cell.2013.11.030
50. Pineau, I., and S. Lacroix. 2007. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J. Comp. Neurol. 500:267-285. http://dx.doi.org/10.1002/cne.21149
51. Proebstl, D., M.B. Voisin, A. Woodfin, J. Whiteford, F. D'Acquisto, G.E. Jones, D. Rowe, and S. Nourshargh. 2012. Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. J. Exp. Med. 209:1219-1234. http://dx.doi.org/10.1084/jem.20111622
52. Rider, P., Y. Carmi, E. Voronov, and R.N. Apte. 2013. Interleukin-1α. Semin. Immunol. 25:430-438. http://dx.doi.org/10.1016/j.smim.2013.10.005
53. Roy, M., J.F. Richard, A. Dumas, and L. Vallières. 2012. CXCL1 can be regulated by IL-6 and promotes granulocyte adhesion to brain capillaries during bacterial toxin exposure and encephalomyelitis. J. Neuroinflammation. 9:18. http://dx.doi.org/10.1186/1742-2094-9-18
54. Rumble, J.M., A.K. Huber, G. Krishnamoorthy, A. Srinivasan, D.A. Giles, X. Zhang, L. Wang, and B.M. Segal. 2015. Neutrophil-related factors as biomarkers in EAE and MS. J. Exp. Med. 212:23-35. http://dx.doi.org/10.1084/jem.20141015
55. Samoilova, E.B., J.L. Horton, B. Hilliard, T.S. Liu, and Y. Chen. 1998. IL-6-deficient mice are resistant to experimental autoimmune encephalomy-elitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161:6480-6486.
56. Schiffenbauer, J., W.J. Streit, E. Butfiloski, M. LaBow, C. Edwards III, and L.L. Moldawer. 2000. The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor. Clin. Immunol. 95:117-123. http://dx.doi.org/10.1006/clim.2000.4851
57. Seppi, D., M. Puthenparampil, L. Federle, S. Ruggero, E. Toffanin, F. Rinaldi, P. Perini, and P. Gallo. 2014. Cerebrospinal fluid IL-1ß correlates with cortical pathology load in multiple sclerosis at clinical onset. J. Neuroimmunol. 270:56-60. http://dx.doi.org/10.1016/j.jneuroim.2014.02.014
58. Shen, Z., Z. Lu, P.Y. Chhatbar, P. O'Herron, and P. Kara. 2012. An artery-specific fluorescent dye for studying neurovascular coupling. Nat. Methods. 9:273-276. http://dx.doi.org/10.1038/nmeth.1857
59. Soulet, D., A. Paré, J. Coste, and S. Lacroix. 2013. Automated filtering of intrinsic movement artifacts during two-photon intravital microscopy. PLoS One. 8:e53942. http://dx.doi.org/10.1371/journal.pone.0053942
60. Steinbach, K., M. Piedavent, S. Bauer, J.T. Neumann, and M.A. Friese. 2013. Neutrophils amplify autoimmune central nervous system infiltrates by maturing local APCs. J. Immunol. 191:4531-4539. http://dx.doi.org/10.4049/jimmunol.1202613
61. Stockinger, B., and M. Veldhoen. 2007. Differentiation and function of Th17 T cells. Curr. Opin. Immunol. 19:281-286. http://dx.doi.org/10.1016/j.coi.2007.04.005
62. Stromnes, I.M., and J.M. Goverman. 2006. Active induction of experimental allergic encephalomyelitis. Nat. Protoc. 1:1810-1819. http://dx.doi.org/10.1038/nprot.2006.285
63. Sutton, C., C. Brereton, B. Keogh, K.H. Mills, and E.C. Lavelle. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203:1685-1691. http://dx.doi.org/10.1084/jem.20060285
64. Sutton, C.E., S.J. Lalor, C.M. Sweeney, C.F. Brereton, E.C. Lavelle, and K.H. Mills. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from γδ T cells, amplifying Th17 responses and autoimmunity. Immunity. 31:331-341. http://dx.doi.org/10.1016/j.immuni.2009.08.001
65. Tung, J.W., K. Heydari, R. Tirouvanziam, B. Sahaf, D.R. Parks, L.A. Herzenberg, and L.A. Herzenberg. 2007. Modern flow cytometry: a practical approach. Clin. Lab. Med. 27:453-468. http://dx.doi.org/10.1016/j.cll.2007.05.001
66. Vallières, N., J.L. Berard, S. David, and S. Lacroix. 2006. Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord. Glia. 53:103-113. http://dx.doi.org/10.1002/glia.20266
67. Vela, J.M., E. Molina-Holgado, A. Arévalo-Martín, G. Almazán, and C. Guaza. 2002. Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol. Cell. Neurosci. 20:489-502. http://dx.doi.org/10.1006/mcne.2002.1127
68. Williams, M.R., N. Kataoka, Y. Sakurai, C.M. Powers, S.G. Eskin, and L.V. McIntire. 2008. Gene expression of endothelial cells due to interleukin-1 beta stimulation and neutrophil transmigration. Endothelium. 15:73-84. http://dx.doi.org/10.1080/10623320802092443
69. Yao, Y., H. Matsushima, J.A. Ohtola, S. Geng, R. Lu, and A. Takashima. 2015. Neutrophil priming occurs in a sequential manner and can be visualized in living animals by monitoring IL-1ß promoter activation. J. Immunol. 194:1211-1224. http://dx.doi.org/10.4049/jimmunol.1402018
70. Yona, S., K.W. Kim, Y. Wolf, A. Mildner, D. Varol, M. Breker, D. Strauss-Ayali, S. Viukov, M. Guilliams, A. Misharin, et al. 2013. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 38:79-91. http://dx.doi.org/10.1016/j.immuni.2012.12.001
71. Zsebo, K.M., V.N. Yuschenkoff, S. Schiffer, D. Chang, E. McCall, C.A. Dinarello, M.A. Brown, B. Altrock, and G.C. Bagby Jr. 1988. Vascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF. Blood. 71:99-103.